| Similar Articles |
|---|
 |
Salon.com
February 22, 2000
Michael Massing |
The elephant in the room Presidential candidates are silent on the failure of the U.S. war on drugs.   |
Salon.com
January 17, 2001
Dawn MacKeen |
Could Ashcroft roll back drug policy reform? Bush's choice for attorney general might halt efforts to emphasize treatment over incarceration, opponents fear... |
Salon.com
August 30, 2000
Arthur Allen |
Portrait of a drug czar Gen. Barry McCaffrey drives his government office like a lockstep battalion, but some contend his ruthless schedule and egomaniacal ways are only hurting his effort to bring sanity to America's drug policy. |
Salon.com
June 7, 2001
Laura Miller |
The nightmare of recovery A powerful new book on the drug war's trenches argues that treatment is the answer -- but our current system dooms more addicts than it helps... |
Salon.com
July 31, 2000
Bruce Shapiro |
Hard time for soft crimes Two million Americans are locked up, most for nonviolent drug offenses. Some maverick Republicans -- yes, Republicans -- are trying to change that. |
Reason
November 2000
Charles Paul Freund |
The New Presidential Identity Nobody ever accused American presidential politics of suffering from too much dignity, but the 2000 election has been a singularly post-labial affair... |
Reason
January 2001
Michael W. Lynch |
America's Most Dangerous Politician I've been in New Mexico less than 10 minutes when I realize that no ordinary politician rules the Land of Enchantment... |
Reason
June 2000
Nick Gillespie |
Albert Agonistes What Gore's winning storyline tells us about politicians |
Reason
January 2002
Michael W. Lynch |
Battlefield Conversions Reason talks with three ex-warriors who now fight against the War on Drugs... |
Salon.com
October 30, 2002
Nell Bernstein |
The drug war's littlest victims Measures to put drug abusers in rehab instead of jail could rescue their kids from the cycle of addiction, foster care and crime. |
IndustryWeek
February 17, 2010
Jonathan Katz |
Rethinking Drug Testing For years it's been a no-brainer on the plant floor, but what do drug screens really tell us? |
Salon.com
August 29, 2000
Bruce Shapiro |
Prison politics Under Gov. George W. Bush, Texas has the largest -- and fastest growing -- incarcerated population in America. |
Reason
June 2007
Gillespie et al. |
Presidential Scouting Reports A libertarian fan's guide to the World Series of politics |
Salon.com
March 29, 2001
Maria Russo |
Psycho factories Nonviolent criminals go in and sadistic thugs come out, but with military spending down, America's small towns are hooked on prisons... |
Reason
March 2001
Nick Gillespie |
The 13th Step Even some drug war opponents buy into its lies... |
Salon.com
February 14, 2001
Earl Ofari Hutchinson |
Another pardon that stinks Clinton pardoned a well-connected cocaine kingpin -- while letting countless low-level, mostly black and Latino, dealers rot in prison... |
Salon.com
March 29, 2001
Damien Cave |
The business of law and order The author of "Going up the River" says that the booming private-prison industry is due for a bust... |
BusinessWeek
April 28, 2011
Karen Weise |
U.S. Courts Face Backlogs and Layoffs Prominent lawyers warn that court budget cuts will harm the economy. |
The Motley Fool
May 26, 2011
Brian Orelli |
Congress Sets Bad Precedent With AVANIR What happened to free markets? |
Salon.com
January 9, 2001
Arianna Huffington |
The right stuff President-elect Bush should make reform-minded New Mexico Gov. Gary Johnson his drug czar... |
Salon.com
October 12, 2000
Gary Kamiya |
Reefer madness America's surreal hypocrisy about recreational drugs has reached the full-blown Dali stage... |
The Motley Fool
July 30, 2010
Brian Orelli |
A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs. |
The Motley Fool
August 31, 2010
Brian Orelli |
Drugmakers May Lose a Back Door for Drug Approval Non-inferiority trials may be inferior. |
Reason
February 2001
Nick Gillespie |
Bill Clinton's Exit Interviews The outgoing president enters his final spin cycle... |
Salon.com
January 30, 2002
John W. Dean |
Vote of no confidence A self-described "election junkie" surveys dozens of books about the 2000 presidential contest and arrives at some troubling conclusions... |
The Motley Fool
April 6, 2011
Brian Orelli |
Merck Inspired to Eye Growth A bolt-on acquisition of eye-care specialist Inspire. |
The Motley Fool
July 12, 2010
Ryan McBride |
Synta Pharma CEO Trumpets New Top Cancer Drug Synta Pharmaceuticals has been climbing back from one of the Boston area's highest-profile clinical trial failures of 2009. |
Reason
Aug/Sep 2001
John J. Pitney, Jr. |
Chad All Over Assessing the 2000 presidential election... |
Reason
June 2001 |
Negotiating Traffic I agree wholeheartedly with Nick Gillespie's editorial on Traffic... There was never any valid reason to outlaw drugs in the first place... etc. |
Chemistry World
July 16, 2010
Matt Wilkinson |
Bittersweet victory for GSK's Avandia GlaxoSmithKline has received a muted 'thumbs up' from a US regulatory advisory panel for its much-maligned Type 2 diabetes drug Avandia (rosiglitazone), making it likely the US Food and Drug Administration will allow the UK-based pharma giant to continue selling the drug in the US. |
Reason
January 2001
Nick Gillespie |
Presidential Blowup In an election more obscure than an Antonioni film, Bill Clinton's real legacy comes into focus... |
Reason
June 2008
Gene Healy |
The Cult of the Presidency Who can we blame for the radical expansion of executive power? Look no further than you and me. |
BusinessWeek
June 4, 2007
Richard S. Dunham |
Execs On The Sidelines With no clear front-runner, few bosses are betting on GOP hopefuls. |
The Motley Fool
April 15, 2011
Luke Timmerman |
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug Will this drug be approved in Europe? |
TIME Asia
May 30, 2011
Andrew Marshall |
Drugged Out Northern Laos was once notorious for opium, and its derivative, heroin. Together with Thailand and Burma, this mountainous region makes up the Golden Triangle, which once provided at least half of the world's opium supply. |
Reason
January 2009
Matt Welch |
Obama's Numbers The president-elect has promised to make his math add up. Therein lies a glimmer of possibility. |
Reason
November 2000
Nick Gillespie |
Being Al Gore The "Real" Appeal of The Kiss... |
The Motley Fool
September 15, 2010
Brian Orelli |
Drug Approved. Now Let's Sell This Baby! With ink still wet on its FDA approval, Savient continues its plan to find a buyer. |
The Motley Fool
December 31, 2010
Brian Orelli |
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. |
The Motley Fool
March 4, 2010
Brian Orelli |
A Painless Drug Deal Bristol-Myers licenses pain drug from Allergan. |
The Motley Fool
June 3, 2011
Brian Orelli |
FDA Bullies Obesity Drugmakers It's been clear for some time that the Food and Drug Administration isn't particularly fond of obesity drugs. Now it's just being a bully. |
Job Journal
December 10, 2006
Rich Heintz |
Job-Search Lessons from the Campaign Trail An election is much like a job search. Political candidates (applicants) go all out to convince voters (employers) that they are the best choice for the job. Here is a landslide of job-hunting lessons from election day. |
Reason
May 2007
Cathy Young |
Assault Behind Bars How big a problem is prison rape in the U.S. -- and what can be done about it? |
Mother Jones
June 2000
Barry Yeoman |
Steel Town Lockdown Corrections Corporation of America is trying to turn Youngstown, Ohio, into the private-prison capital of the world. |
Wired
May 2006
Karen Breslau |
The Ressurection of Al Gore He invented the Internet (sort of). He became President (almost). Now Al Gore has found his true calling: using the power of technology to save the world. |
The Motley Fool
May 2, 2011
Tim Beyers |
Spectrum Pharmaceuticals Shares Popped: What You Need to Know Shares of Spectrum Pharmaceuticals rose as much as 14% in intraday trading after the Food and Drug Administration approved Fusilev as a colon cancer treatment. |
The Motley Fool
April 22, 2011
Sean Williams |
Pharma's Most Perilous Pipelines Patent expirations expose weaknesses for these Wall Street darlings. |
The Motley Fool
March 31, 2011
Brian Orelli |
Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good. |
Salon.com
July 20, 2000
Nell Bernstein |
Swept away Thousands of women, often guilty of little more than lousy judgment, are serving long prison sentences as drug "conspirators." |
The Motley Fool
June 3, 2011
Frank Vinluan |
GSK Sees Positive Results on Asthma, COPD Drug Expected to Succeed Advair GSK gets good news. |
